Short interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) increased during the last reporting period, rising from 5.32M to 6.56M. This put 10.89% of the company's publicly available shares short.

Based on the recent average volume of 1.86M shares traded per day, it would take 3.53 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.